Abstract:According to global prevalence analysis studies, acute upper respiratory tract infections (URTIs) are the most common acute infectious disease in children, especially in preschool children. Acute URTIs lead to an economic burden on families and society. Vitamin A refers to the fat‐soluble compound all‐trans‐retinol and also represents retinol and its active metabolites. Vitamin A interacts with both the innate immune system and the adaptive immune system and improves the host's defences against infections. Correlation studies show that serum retinol deficiency was associated with a higher risk of respiratory tract infections. Therefore, vitamin A supplementation may be important in preventing acute URTIs. To assess the effectiveness and safety of vitamin A supplements for preventing acute upper respiratory tract infections in children up to seven years of age. We searched CENTRAL, MEDLINE, Embase, the Chinese Biomedical Literature Database, and two trial registration platforms to 8 June 2023. We also checked the reference lists of all primary studies and reviewed relevant systematic reviews and trials for additional references. We imposed no language or publication restrictions. We included randomised controlled trials (RCTs), which evaluated the role of vitamin A supplementation in the prevention of acute URTIs in children up to seven years of age. We used the standard methodological procedures expected by Cochrane. We included six studies (27,351 participants). Four studies were RCTs and two were cluster‐RCTs. The included studies were all conducted in lower‐middle‐income countries (two in India, two in South Africa, one in Ecuador, and one in Haiti). Three studies included healthy children who had no vitamin A deficiency, one study included children born to HIV‐infected women, one study included low‐birthweight neonates, and one study included children in areas with a high local prevalence of malnutrition and xerophthalmia. In two studies, vitamin E was a co‐treatment administered in addition to vitamin A. We judged the included studies to be at either a high or unclear risk of bias for random sequence generation, incomplete outcome data, and blinding. Primary outcomes Six studies reported the incidence of acute URTIs during the study period. Five studies reported the number of acute URTIs over a period of time, but there was population heterogeneity and the results were presented in different forms, therefore only three studies were meta‐analysed. We are uncertain of the effect of vitamin A supplementation on the number of acute URTIs over two weeks (risk ratio (RR) 1.00, 95% confidence interval (CI) 0.92 to 1.09; I 2 = 44%; 3 studies, 22,668 participants; low‐certainty evidence). Two studies reported the proportion of participants with an acute URTI. We are uncertain of the effect of vitamin A supplementation on the proportion of participants with an acute URTI (2 studies, 15,535 participants; low‐certainty evidence). Only one study (116 participants) reported adverse events. No infant in either the placebo or vitamin A group was found to have feeding difficulties (failure to feed or vomiting), a bulging fontanelle, or neurological signs before or after vitamin A administration (very low‐certainty evidence). Secondary outcomes Two studies (296 participants) reported the severity of subjective symptoms, presented by the mean duration of acute URTI. Vitamin A may have little to no effect on the mean duration of acute URTI (very low‐certainty evidence). The evidence for the use of vitamin A supplementation to prevent acute URTI is uncertain, because population, dose and duration of interventions, and outcomes vary between studies. From generally very low‐ to low‐certainty evidence, we found that there may be no benefit in the use of vitamin A supplementation to prevent acute URTI in children up to seven years of age. More RCTs are needed to strengthen the current evidence. Future research should report over longer time frames using validated tools and consistent reporting, and ensure adequate power calculations, to allow for easier synthesis of data. Finally, it is important to assess vitamin A supplementation for preschool children with vitamin A deficiency. Background Acute upper respiratory tract infections (URTIs) are the most common acute infectious diseases in children, especially in preschool children. Vitamin A has a positive role in the immune system and may improve the host's defences against infections. Studies show that children with vitamin deficiency are more likely to suffer from respiratory tract infections. Therefore, we assessed the role of vitamin A supplementation in the prevention of acute upper respiratory tract infections in preschool children (up to seven years of age). Review question What is the role of vitamin A supplementation in the prevention of acute URTIs in preschool childr -Abstract Truncated-

Randomised, double blind, placebo controlled clinical trial of efficacy of vitamin A treatment in non-measles childhood pneumonia

Efficacy and inflammatory levels (IL-6, IL-10) of adjuvant application of vitamin-A in the treatment of pediatric Mycoplasma pneumoniae pneumonia: a systematic review and meta-analysis

Efficacy and safety of vitamin C supplementation in the treatment of community-acquired pneumonia: a systematic review and meta-analysis with trial sequential analysis

Role of vitamin C in treatment of community-acquired pneumonia in adult patients requiring hospitalisation: a systematic review protocol

Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial

Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis

Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study

Evaluation of vitamin D status effect on the outcome of children hospitalized with acute respiratory illnesses at a paediatrics referral hospital, Kenya

Clinical Study on Vitamin A Status and Significance of Supplement in Premature Infants

Can Vitamin D Supplementation Reduce Risk of Recurrence of Pneumonia in Under-Five Children?

Multiple Micronutrient Powder Reduces Vitamin E Deficiency in Brazilian Children: A Pragmatic, Controlled Clinical Trial

Etiology of severe pneumonia in Ecuadorian children

Association between vitamin A supplementation and stunting and anemia in socially vulnerable Brazilian children

Synbiotic or Zinc supplementation in the treatment of children with bacterial pneumonia, a double-blinded randomized clinical trial

A 12 week double-blind randomised controlled trial investigating the effect of dietary supplementation with 5000 IU/day (125 μg/day) vitamin D in adults with asthma, led to an improvement in the lung function parameter - FEV1:FVC ratio

Vitamin A supplementation prevents the bronchopulmonary dysplasia in premature infants: A systematic review and meta-analysis

Serum Micronutrients as related to Childhood Pneumonia Severity and Outcome in a Nigerian Health Facility

Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial

Efficacy of Zinc Given As an Adjunct to the Treatment of Severe Pneumonia: A Meta‐analysis of Randomized, Double‐blind and Placebo‐controlled Trials

Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age

Vitamin A Deficiency is Associated with Severe Mycoplasma Pneumoniae Pneumonia in Children